• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2025: $113 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Menu Menu

  • Sort by Price
    • Default
    • Custom
    • Name
    • Price
    • Date
    • Popularity (sales)
    • Average rating
    • Relevance
    • Random
    • Product ID
  • Click to order products ascending
  • Display 15 Products per page
    • 15 Products per page
    • 30 Products per page
    • 45 Products per page
    Wound Care Markets, 4th. Edition, Vol. III: Surgical and Trauma Wounds

    Published: May 1, 2009 | Price: $2,995.00 – $5,990.00

    There are millions of surgical procedures performed annually worldwide and the market for wound care products and techniques is significant. Surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area and thus an important market. Kalorama Information's Wound Care Series offers one of the most complete market round-ups published recently, featuring the following: This is the only recently published market research study to provide Wound Care Revenues by Condition/Treatment. This report,...
    Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems

    Published: September 1, 2009 | Price: $2,995.00 – $5,990.00

    With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets. Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports...
    SNP and Whole Genome Sequencing Market Research Bundle

    Published: April 1, 2010 | Price: $2,995.00 – $5,990.00

    This report combines two of Kalorama's latest research volumes DNA Sequencing and SNP Genotyping and Analysis Markets into one package, and includes a preface on the complementary/competitive use of SNP Analysis and whole-genome sequencing on topics and the impact of the results of GWAS on the market.
    Infusion Pump Markets (Large Volume, Ambulatory, Insulin, Enteral and Other Pumps)

    Published: October 1, 2010 | Price: $2,995.00 – $5,990.00

    Infusion pumps are used to infuse necessary fluids, which includes medications and/or nutrients, to a patient’s circulatory system. This Kalorama Information report, Infusion Pump Markets (Large Volume, Ambulatory, Disposable, Syringe, and Specialty Infusion Pumps) covers markets for these products in several product segments. Estimates and Forecasts of Infusion Pump Markets For the purpose of this study, we have classified two general types of infusion pumps: General Purpose Infusion Pumps and Specialty Infusion Pumps General purpose infusion pumps are used in...
    The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition

    Published: July 27, 2012 | Price: $2,995.00 – $7,990.00

    In eight best-selling editions, Shara Rosen has detailed the market for in vitro diagnostic (IVD) testing, throughout the world,  in one complete volume. The report, The Worldwide Market for In Vitro Diagnostic Tests, is a testament to the Kalorama methodology. Real industry knowledge combined with an exhaustive review of the medical, business, and company literature. Market numbers for business planning matched with a discovery of the trends that are impacting the industry. A realistic forecast five years into the future...
    The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives

    Published: May 8, 2013 | Price: $2,995.00 – $6,750.00

    The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence. The market for cancer testing are comprehensively covered in Kalorama Information's Worldwide Market for Cancer Diagnostics, 5th. Edition. This report, authored by Kalorama Diagnostic Analyst Shara Rosen, contains detailed market data on the following IVD segments for...
    The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

    Published: September 22, 2013 | Price: $2,995.00 – $6,000.00

    The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others), is designed to provide a comprehensive look at the various strategies being used by select worldwide generic companies in exploring the emerging area of biosimilars, the issues and trends that are shaping the marketplace, and the potential feasibility of providing biosimilars within the United States regulatory environment....
    The Market and Potential for Molecular Point of Care Diagnostics: Forecasts to 2018

    Published: February 5, 2014 | Price: $2,995.00 – $5,990.00

    The Market and Potential for Molecular Point of Care Diagnostics Molecular Point of Care is a budding field in medical diagnostics. Kalorama's report, The Market and Potential for Molecular Point of Care Diagnostics, provides the most current look at this field. To assess the opportunity, Kalorama's report examines the molecular diagnostics business and also the point-of-care (POC) diagnostics business as they are now, and then examines at the new combination products.   A good number of companies are producing or...
    Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)

    Published: January 8, 2018 | Price: $2,995.00 – $5,990.00

    Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)Tumor Markers Immunoassay Market analyzes the current world market, including tumor markers immunoassay revenues by marker, 2015-2025 (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others, Total); regional revenues for tumor markers immunoassays, 2015-2025 (US, EU, ROW, Total); attributes of selected tumor marker immunoassays (cancer type, tissue analyzed, how used); and selected...
    Point of Care (POC) Infectious Disease Diagnostic Testing Market

    Published: March 22, 2018 | Price: $2,995.00 – $5,995.00

    This Kalorama Information report, Point of Care Infectious Disease Diagnostic Testing provides market sizing and forecasts for the following disease areas Influenza STD HIV Hepatitis Malaria C. difficile E. coli H. pylori Home Test/OTC Others Point of care testing market features competitors that are large major concerns as well as newer entrants and specialist players.  As part of its coverage, the report also profiles competitors in the market, including the following: Abbott/Alere Atlas Genetics Ltd. Atlas Link Biotech Co., Ltd...
    Disruption in Healthcare: Amazon, Brexit, Trump, MACRA, Gig Workers, Aging – 27 Factors That Could Change the Business

    Published: March 27, 2018 | Price: $2,995.00 – $5,990.00

      In healthcare, there are 27 potential disruptors that could have a large impact on the market.  This report discusses them and how they will impact markets in healthcare and pharmaceuticals: • New US Healthcare Policies/ACA Status • Reimbursement Changes in Europe and Other Developed Nations • Brexit • Emerging Countries • Demographic Changes • Ransomware and Blockchain Strategies • Telemedicine • Walk-in Clinics • MACRA • Empowered Consumers • "Gig" Economy • Value-Based Reimbursement • Brazilian Biotech Market •...
    U.S. Market for OTC Diet Aids, The

    Published: February 1, 2004 | Price: $3,000.00 – $6,000.00

    Diet Aids are among the most rapidly growing categories of over-the-counter (OTC) products. Between 1998 and 2003, growth was driven by two main factors: changes in laws and lawsuits relating to the industry, and changes in consumer attitudes toward weight loss. Because both of these factors are subject to rapid and unpredictable shifts, the diet aids category remains a highly volatile market. The consumer attitude towards OTC diet aids has shown extreme changes during the last couple of years. While...
    The U.S. Market for Over-The-Counter Pain Medication

    Published: January 1, 2005 | Price: $3,000.00 – $6,000.00

    The U.S. market for Over-the-Counter (OTC) Pain Medication presents an in-depth analysis of the performance of various analgesics, including non-steroidal anti-inflammatory drugs (NSAID) and topical products in the US market. The analysis captures the performance of the market players, categories and leading brands in terms of revenue growth and volume growth. It also identifies key issues, drivers, challenges, regulations and trends affecting the marketplace. The report provides a comprehensive analysis of the pain medication products that are currently in the...
    Informatics in Drug Discovery: The Evolving Information Technology Marketplace

    Published: May 1, 2005 | Price: $3,000.00 – $6,000.00

    Within the world of life science research, informatics plays a key role. A few years ago, this market space was occupied primarily by a few niche players, but over the past five years, established companies have expanded their offerings and hundreds of new software companies have surfaced. In the rapidly changing field of informatics, it is difficult to decode the buzz-words, interpret the extravagant claims, separate true needs from blue-sky wishes. The concerns and strategies of only a year ago...
    The U.S Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medications

    Published: July 1, 2005 | Price: $3,000.00 – $6,000.00

    This report on the U.S. market for over-the-counter (OTC) cough, cold, sinus and allergy (CCSA) medication presents an in-depth analysis of the performance of various CCSA drugs in the U.S. market. The analysis captures the performance of the market players, drug categories, and leading brands in terms of revenues and growth. It also identifies key issues, drivers, challenges, regulations, and trends affecting the marketplace. In addition, the report provides a detailed analysis of consumer demographics and preferences in terms of...
Page 32 of 60«‹3031323334›»

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Latest CDC Findings: A Wake‑Up Call for the $1.3 Billion Global Sepsis Diagnostics Market April 6, 2026
  • NAMs, NIH Policy, and What it Means for Diagnostics March 20, 2026
  • As Flu Outpaces COVID This Winter, Rapid Molecular Testing Takes on New Importance March 17, 2026
  • March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
  • Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Scroll to top